After the successful launch of the first H1N1 vaccine "fluvac", an hyderabad-based biotechnology firm Bharat Biotech, has launched India's first indigenously developed cell culture Swine Flu Vaccine HNVAC. The vaccine is developed using culture technology by which cells are grown under controlled conditions.
The H1N1 vaccine HNVAC has been proved as safe & resistible after the trials in various phases. The biotech firm is proud to offer such vaccine, which has been developed using unique technology in India. As there are number of people, who were exempted from Swine flu vaccine last year, the company is trying to make it available for Indian consumers at affordable cost.
No comments:
Post a Comment